Stock screener

CGEM

Conviction 95HealthcareScan · Thu, Jun 25, 2026
CGEM$18.49+4.73%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 1.68M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Cullinan Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cullinantherapeutics.com ↗
Price18.49
Change+4.73%
Gap+0.28%
Rel volume1.75×
Avg volume1.52M
Avg $ vol22.93M
SMA 2014.98
SMA 5014.68
SMA 20011.63
Price vs 50+25.89%
Price vs 200+58.89%
MA stackbullish
50/200 cross—
Supertrendup · 14.26
RSI (14)71
MACD hist0.54
MACD crossbull · 4d
Stoch %K / %D96 / 92
ADX (14)21
+DI / −DI34 / 16
RSI divergenceBearish
MACD divergenceBearish
ATR %+6.70%
ADR %8.53%
52w high18.49
52w low5.75
From 52w high+0.00%
Above 52w low+221.48%
New 52w highYes
SqueezeOff
Bollinger width47.58%
%B0.99
Donchian pos96.12%
Donchian high18.76
Donchian low11.68
AVWAP (52w high)18.15
vs AVWAP high+1.85%
AVWAP (52w low)12.10
vs AVWAP low+52.76%
OBV trendFlat
Chaikin MF (20)0.05
Today vs 20d1.75×
Avg vol (14d)1.68M
Avg vol (20d)1.52M
Avg $ vol (20d)22.93M
Market cap1.14B
RS 3m (vs SPY)+17.14%
RS 6m (vs SPY)+74.60%
RS line new highNo
Trend template8/8
Technical rank94.5
1 week+28.01%
1 month+19.57%
3 months+31.47%
6 months+78.77%
1 year+135.78%
YTD+82.66%
P/E-5.17
P/B2.78
P/S—
P/FCF-6.46
EPS-3.69
Div yield—
ROE-53.80%
ROA-54.56%
Debt/Eq—
Current10.28
EV/EBITDA-4.40
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-31.36%
Price target33.56
Target upside81.55%
Analyst ratingBuy
Institutional112.72%
Ent. value1.06B
Revenue0
Net income-50.61M
Gross profit—
Free cash flow-175.8M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out61.46M
Employees109
ListedFri, Jan 8, 2021
Free float47.04M
Float %79.6%
Short interest7.97M
Days to cover7.0d
Short volume61.4%
Squeeze score84 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.71 · 5 est
Last EPS vs est−$0.75 vs −$0.80
Last surprise+6.3% beat
Setup gradeA+
Conviction95 / 100
Pattern quality—
Tech rank94.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.63
Support12.51
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Sep 30, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in CGEM

All disclosures →
No recent disclosed trades by Congress in CGEM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CGEM · 7 buys · 3 sells

InsiderSideShares
Allen Andrew R
Director · Stock Option (Right to Buy) · 2026-06-16
Grant21.78K
Doyle Mittie
Director · Stock Option (Right to Buy) · 2026-06-16
Grant21.78K
Thistle Mary
Director · Stock Option (Right to Buy) · 2026-06-16
Grant25.32K
Webster Stephen W
Director · Stock Option (Right to Buy) · 2026-06-16
Grant25.32K
Meek David D.
Director · Stock Option (Right to Buy) · 2026-06-16
Grant25.32K
Rosenberg Anthony
Director · Stock Option (Right to Buy) · 2026-06-16
Grant25.32K
Michaelson Jennifer
Chief Scientific Officer · Stock Option (Right to Buy) · 2026-05-05
Exercise4K
Michaelson Jennifer
Chief Scientific Officer · Common Stock · 2026-05-05
Sell200
Michaelson Jennifer
Chief Scientific Officer · Common Stock · 2026-05-05
Sell7.8K
Michaelson Jennifer
Chief Scientific Officer · Common Stock · 2026-05-05
Exercise4K

SEC filings

EDGAR filings in CGEM · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.